The observation that heart failure with reduced ejection fraction is associated with elevated
circulating levels of pro-inflammatory cytokines opened a new area of research that has …

Inflammation has been recognized as a major pathophysiological contributor to the entire
spectrum of human heart failure (HF), including HF with reduced ejection fraction, HF with …

Elevated levels of inflammatory mediators have been identified in patients with heart failure,
including heart failure with reduced and preserved ejection fraction, as well as acute …

Abstract Purpose of Review This paper aims to discuss the interactions between
inflammatory cytokines, immune cells, and heart failure (HF). The association of heart failure …

Elevated levels of circulating pro‐inflammatory biomarkers in patients with both ischaemic
and non‐ischaemic heart failure (HF) correlate with disease severity and prognosis …

Heart failure results not only from cardiac overload or injury but also from a complex
interplay among genetic, neurohormonal, inflammatory, and biochemical changes acting on …

Evidence from both experimental and clinical trials indicates that inflammatory mediators are
of importance in the pathogenesis of chronic heart failure (HF) contributing to cardiac …

Non-alcoholic fatty liver disease (NAFLD) represents the most common and emerging
chronic liver disease worldwide. It includes a wide spectrum of liver diseases ranging from …

Millions of people around the world suffer from psychiatric illnesses, causing unbearable
burden and immense distress to patients and their families. Accumulating evidence …

Cardiac cachexia as a terminal stage of chronic heart failure carries a poor prognosis. The
definition of this clinical syndrome has been a matter of debate in recent years. This review …